Literature DB >> 12820394

Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate.

Hiroko Fujii1, Osamu Amano, Mutsuyuki Kochi, Hiroshi Sakagami.   

Abstract

Previous studies have demonstrated the dramatic antitumor activity of sodium 5,6-benzylidene-L-ascorbate (SBA). However, the molecular mechanism of this antitumor action is unclear. We investigated the changes in the fine structures of a human submandibular gland carcinoma cell line, HSG, during the cell death induced by SBA. When HSG cells were incubated for 6 hours with non-cytotoxic concentrations of SBA, changes in the mitochondria, such as the disassembly of cristae and decrease in the electron density, were discrenible. At cytotoxic concentrations, the swelling and vacuolization of the mitochondria became apparent, while the nuclear architecture including the profile and ratio of heterochromatin and euchromatin and thickness of the nuclear membrane were intact. These data suggest that the mitochondria, not the nucleus, may be the target organelle of SBA, and support the ability of SBA to induce non-apoptotic cell death in HSG cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820394

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer.

Authors:  Christopher M Stephenson; Robert D Levin; Thomas Spector; Christopher G Lis
Journal:  Cancer Chemother Pharmacol       Date:  2013-05-14       Impact factor: 3.333

2.  Mieap suppresses murine intestinal tumor via its mitochondrial quality control.

Authors:  Masayuki Tsuneki; Yasuyuki Nakamura; Takao Kinjo; Ruri Nakanishi; Hirofumi Arakawa
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.